Educational recommendations for the conduct, content and format of EULAR musculoskeletal ultrasound Teaching the Teachers Courses

To produce educational guidelines for the conduct, content and format of theoretical and practical teaching at EULAR musculoskeletal ultrasound (MSUS) Teaching the Teachers (TTT) Courses

High star formation rates as the origin of turbulence in early and modern disk galaxies

High spatial and spectral resolution observations of star formation and kinematics in early galaxies have shown that two-thirds are massive rotating disk galaxies with the remainder being less massive non-rotating objects. The line of sight averaged velocity dispersions are typically five times higher than in today's disk galaxies. This has suggested that gravitationally-unstable, gas-rich disks in the early Universe are fuelled by cold, dense accreting gas flowing along cosmic filaments and penetrating hot galactic gas halos. However these accreting flows have not been observed, and cosmic accretion cannot power the observed level of turbulence. Here we report on a new sample of rare high-velocity-dispersion disk galaxies we have discovered in the nearby Universe where cold accretion is unlikely to drive their high star-formation rates. We find that the velocity dispersion is most fundamentally correlated with their star-formation rates, and not their mass nor gas fraction, which leads to a new picture where star formation itself is the energetic driver of galaxy disk turbulence at all cosmic epochs.Comment: 9 pages, 2 figures, Supplimentary Info available at: http://pulsar.swin.edu.au/~agreen/nature/sigma_mean_arXiv.pdf. Accepted for publication in Natur

Astrometric confirmation of young low-mass binaries and multiple systems in the Chamaeleon star-forming regions

The star-forming regions in Chamaeleon are one of the nearest (distance ~165 pc) and youngest (age ~2 Myrs) conglomerates of recently formed stars and the ideal target for population studies of star formation. We investigate a total of 16 Cha targets, which have been suggested, but not confirmed as binaries or multiple systems in previous literature. We used the adaptive optics instrument Naos-Conica (NACO) at the Very Large Telescope Unit Telescope 4 of the Paranal Observatory, at 2-5 different epochs, in order to obtain relative and absolute astrometric measurements, as well as differential photometry in the J, H, and K band. On the basis of known proper motions and these observations, we analyse the astrometric results in our "Proper Motion Diagram" (PMD: angular separation / position angle versus time), to eliminate possible (non-moving) background stars, establish co-moving binaries and multiples, and search for curvature as indications for orbital motion. All previously suggested close components are co-moving and no background stars are found. The angular separations range between 0.07 and 9 arcseconds, corresponding to projected distances between the components of 6-845 AU. Thirteen stars are at least binaries and the remaining three (RX J0919.4-7738, RX J0952.7-7933, VW Cha) are confirmed high-order multiple systems with up to four components. In 13 cases, we found significant slopes in the PMDs, which are compatible with orbital motion whose periods range from 60 to 550 years. However, in only four cases there are indications of a curved orbit, the ultimate proof of a gravitational bond. Massive primary components appear to avoid the simultaneous formation of equal-mass secondary components. (abridged)Comment: 33 pages, 22 figures, accepted for publication in A&A, 2nd version: typos and measurement unit added in Table

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma

Tumor biopsies may help to reliably distinguish hepatocellular carcinoma (HCC) from other tumors, mostly cholangiocarcinoma as well as to identify the patient populations who most benefit from target-driven HCC treatments, in order to improve the success rate of experimental therapies. Clarifying tumor biology may also lead to identify biomarkers with prognostic role and/or enabling to predict response or resistance to therapies. Recently, clinical trials have more efficiently included biomarker endpoints and increasingly collected tumor tissue from enrolled patients. Due to their frail status and sometimes fast-progressing disease, the performance status of patients with HCC progressing on first-line therapy can deteriorate quickly, preventing their enrollment in clinical trials. However, the challenge of identifying the proper patient at the proper time can be overcome by periodic inter-department meetings involving the key specialists taking care of HCC patients, and solid networks between research centers and referring institutions. An early planned biopsy would also facilitate timely inclusion of patients in biology-driven clinical trials. Ultimately, institution of multidisciplinary teams can optimize treatment choice, biopsy timing, and quick enrollment of patients in clinical trials, before their performance status deteriorates